Cardiovascular Epidemiology in Russian Federation

NCT ID: NCT02449460

Last Updated: 2016-08-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

18000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-07-31

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study addresses epidemiology of cardiovascular risk factors and major cardiovascular diseases in Russian Federation (urban and rural population). 12 regions of 1600 participants in each will be included.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Plasma lipids and fasting glucose, heart rate and blood pressure, anthropometry, smoking and alcohol questionaries, nutrition, sleep quality, stress will be assessed. ECG records are obtained form all participants. Subclinical target organ damage (carotid and periferal atherosclerosis, pulse wave velocity) will be measured in selected sites. Brain natriuretic peptide, adipose tissue cytokines, hsCRP and genetic markers are also under evaluation

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypertension Coronary Artery Disease Diabetes Heart Failure Smoking Lifestyle

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- informed consent

Exclusion Criteria

No
Minimum Eligible Age

25 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Research Center for Preventive Medicine

OTHER_GOV

Sponsor Role collaborator

Russian Cardiology Research and Production Center

OTHER

Sponsor Role collaborator

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Conrady Alexandra

professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Svetlana A Shalnova, Prof

Role: STUDY_CHAIR

State Sientific Center of Preventive Medicine

Alexandra O Konradi, Prof

Role: PRINCIPAL_INVESTIGATOR

Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health

Eugene I Chazov, Prof

Role: PRINCIPAL_INVESTIGATOR

Russian Research and Production Complex

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Orenburg Medical Academi

Orenburg, , Russia

Site Status RECRUITING

Samara Medical University

Samara, , Russia

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Russia

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Eugene V Shlyakhto, Prof

Role: CONTACT

78127023700

Sergey A Boytsov, Prof

Role: CONTACT

74953641159

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Roman Libis, Prof

Role: primary

79111555524

Dmitry Duplyakov

Role: primary

79277297273

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AlmazovFCHBE-4

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Epidemiology of Atherosclerosis
NCT00005147 COMPLETED
Pawtucket Heart Health Program
NCT00005151 COMPLETED